Profile data is unavailable for this security.
About the company
Allmed Solutions Ltd, former Allium Medical Solutions Ltd, is an Israel-based company, which develops, manufactures and markets minimally invasive products internationally. Its products are used by physicians to treat a number of diseases and patients worldwide. The Company's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The Company's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.
- Revenue in ILS (TTM)0.00
- Net income in ILS-12.37m
- Incorporated2004
- Employees22.00
- LocationAllmed Solutions LtdHailan 12CAESAREA 3063908IsraelISR
- Phone+972 466277166
- Fax+972 46277266
- Websitehttps://www.allium-medical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Erika Carmel Tech Ltd | 39.63m | -11.45m | 21.25m | -- | -- | 1.59 | -- | 0.5362 | -0.11 | -0.11 | 0.3805 | 0.1286 | 1.04 | 0.9092 | 6.87 | -- | -30.04 | -18.36 | -53.79 | -26.37 | 61.03 | 86.48 | -28.90 | -18.90 | 0.6648 | -12.59 | 0.156 | -- | 27.03 | -5.67 | 50.73 | -- | -33.83 | -- |
| Elbit Medical Technologies Ltd | 2.08m | 851.07k | 21.77m | 232.00 | 25.60 | 0.8905 | -- | 10.48 | 0.0094 | 0.0094 | 0.0229 | 0.2695 | 0.0847 | -- | 36.43 | -- | 3.47 | 54.06 | 3.54 | 55.40 | 12.61 | -- | 40.95 | 61.64 | -- | -- | 0.00 | -- | 282.18 | -39.79 | 104.65 | -- | -- | -- |
| Bio View Ltd | 17.88m | -9.67m | 23.63m | 33.00 | -- | 1.06 | -- | 1.32 | -0.0724 | -0.0724 | 0.1338 | 0.1602 | 0.5047 | 1.23 | 3.73 | 541,848.50 | -27.30 | 0.4609 | -37.17 | 0.6127 | 46.36 | 59.56 | -54.09 | 0.6094 | 1.58 | -10.31 | 0.0854 | -- | -26.21 | -6.44 | -921.93 | -- | -29.98 | -- |
| BioLight Life Sciences Ltd | 21.00k | -14.05m | 29.83m | 4.00 | -- | 0.7906 | -- | 1,420.47 | -2.95 | -2.95 | 0.0044 | 4.17 | 0.0006 | -- | 0.027 | -- | -47.82 | -21.57 | -52.72 | -22.97 | -- | -- | -86,261.91 | -13,619.35 | -- | -2.74 | 0.0051 | -- | 85.59 | -5.91 | 72.55 | -- | -0.6994 | -- |
| Allmed Solutions Ltd | 0.00 | -12.37m | 37.51m | 22.00 | -- | 1.12 | -- | -- | -0.1328 | -0.1328 | 0.00 | 0.3362 | 0.00 | -- | -- | 0.00 | -28.18 | -9.16 | -31.98 | -10.12 | -- | 55.39 | -- | -170.44 | -- | -25.09 | 0.0139 | -- | -- | -- | -715.47 | -- | 8.08 | -- |
| Nissan Medical Industries Ltd | 640.72m | 1.00k | 89.90m | 406.00 | -- | 0.4499 | 3.17 | 0.1403 | -0.0088 | -0.0088 | 72.73 | 22.00 | 0.9296 | 4.12 | 7.14 | 1,578,126.00 | -0.0361 | 3.80 | -0.0792 | 7.11 | 11.36 | 18.52 | -0.0389 | 3.90 | 0.4917 | 0.8917 | 0.3751 | -- | -9.52 | 1.87 | 39.95 | -12.83 | -9.20 | -- |
| Pulsenmore Ltd | 9.31m | -44.00m | 108.34m | 63.00 | -- | 1.41 | -- | 11.64 | -6.86 | -6.86 | 1.45 | 11.81 | 0.066 | 0.2472 | 2.23 | 147,777.80 | -31.20 | -23.53 | -34.52 | -25.32 | 37.36 | -- | -472.58 | -555.16 | 6.44 | -32.44 | 0.2476 | -- | 56.12 | -- | 37.28 | -- | 23.66 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Ayalon Mutual Funds Ltd.as of 30 Nov 2025 | 2.31m | 2.40% |
| Psagot Mutual Funds Ltd.as of 30 Nov 2025 | 322.48k | 0.34% |
